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Abstract: The trans-o-hydroxybenzylidene pyruvate aldolase-
catalysed reactions between fluoropyruvate and many
(hetero)aromatic aldehydes yield aldol adducts without sub-
sequent dehydration. Treatment of the reaction products with
hydrogen peroxide yields the corresponding syn-configured a-
fluoro b-hydroxy carboxylic acids which have > 98% ee. The
overall chemoenzymatic approach, in which fluoropyruvate
serves as a fluoroacetate equivalent, may be exploited in the
synthesis of polar building blocks and fragments with potential
value in drug discovery.
Fluorination can profoundly affect the conformation, bio-
availability, metabolism, pharmacokinetics and pharmacody-
namics of bioactive small molecules.[1] The introduction of
fluorine is therefore widely used to tune biological function,
and around 20% of leading drugs contain at least one fluorine
atom[2] (10 of the top 50 drugs in 2013 by US prescription[3]).
Examples of leading fluorinated pharmaceuticals include the
cholesterol-lowering drug Rosuvastatin[4] and the antidiabetic
drug Sitagliptin.[4]
The controlled formation of fluorine-substituted stereo-
centres, however, presents a significant challenge. Most
usually, the challenge is addressed by stereoselective C¢F
bond formation. For example, the fluorination of allylic
silanes is often diastereoselective,[5] and organo-[6] and Pd-[7]
catalysed methods enable the enantioselective a-fluorination
of carbonyl compounds.
Stereoselective C¢C bond formation could provide a com-
plementary approach for controlling fluorine-bearing stereo-
centres (Scheme 1). However, aldol (and related) reactions of
esters of fluoroacetic acid generally exhibit poor diastereo-
selectivity (e.g. reactions of lithium enolates,[8] Reformatsky
reactions[9] andMukayama aldol reactions[10]). In any case, the
reactants typically used in such aldol reactions (ethyl fluoro-
acetate and sodium fluoroacetate) are toxic.[11] Very recently,
an enantioselective organocatalysed reaction of fluoroma-
lonic acid halfthioesters has been developed that yields the
corresponding anti-configured a-fluoro thioester aldol
adducts.[12] We therefore envisaged a complementary
approach in which fluoropyruvic acid (4) would serve as an
alternative synthetic equivalent for fluoroacetate in an
aldolase-catalysed aldol reaction.[13] Aldolase-catalysed reac-
tion of fluoropyruvate (4) and aldehydes 1 would result in the
formation of a-keto acids 5 which might then be decarboxy-
lated[14] to give the corresponding a-fluoro b-hydroxy carbox-
ylic acids 6. The approach would complement organocata-
lysed reactions that yield other classes of a-fluoro carbonyl
compounds.[12,15]
The Class I (lysine-dependent) aldolase, N-acetyl neura-
minic acid lyase (NAL), has been shown to accept fluoropyr-
uvate as an alternative donor substrate to pyruvate.[16] The
value of NAL in the synthesis of fluorinated products is,
however, limited by poor stereocontrol and narrow demon-
strated substrate scope. Moreover, NAL accepts only poly-
hydroxylated substrates which often yield products as com-
plex anomeric mixtures of both pyranose and furanose forms.
We therefore sought another Class I aldolase that would also
accept fluoropyruvate as a donor, but would have more value
in the synthesis of building blocks[17] for drug discovery.
Scheme 1. Alternative approaches for the conversion of aldehydes
1 into a-fluoro b-hydroxy carboxylic acids 6. a) Reaction with an
enolate of an ester of fluoroacetic acid 2, followed by hydrolysis.
b) Aldolase-catalysed reaction with fluoropyruvic acid (4), followed by
decarboxylation.
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We selected trans-o-hydroxybenzylidene pyruvate hydra-
tase-aldolase (HBPA; EC 4.1.2.45) which catalyses the aldol
reaction between salicylaldehyde (1b) and pyruvate, and
a subsequent dehydration.[18] This enzyme is known to accept
several aromatic aldehydes as substrates[19] in reactions with
pyruvate. Accordingly, we expressed a synthetic gene encod-
ing the Pseudomonas putida enzyme and purified the gene
product in His-tagged form (Supporting Information).
Initially, we screened for catalysis of the reaction between
fluoropyruvate (4) and a range of aromatic and heterocyclic
aldehyde substrates 1 (Supporting Information). Accordingly,
each alternative aldehyde (final concentration: 50 mm),
fluoropyruvate (final concentration: 25 mm) and HBPA
(final concentration: 0.1 mol%) was dissolved in 25 mm
pH 6.0 MES buffer in an NMR tube. In each case, the
conversion into products, and the disappearance of fluoro-
pyruvate, was followed by 282 MHz 19F NMR spectroscopy
(Figure 1A–C and Supporting Information).
The HBPA-catalysed reaction involving fluoropyruvate
(4) as the donor was successful with a wide range of aromatic
and heteroaromatic aldehydes 1 (Figure 1D and Supporting
Information). Unfortunately, no aliphatic aldehydes were
found to be good substrates. The products were generally
obtained with good diastereoselectivity as mixtures of keto
and hydrated forms. Remarkably, dehydration of the products
was not observed, perhaps because the presence of the
fluorine atom precludes enzyme-catalysed elimination. It was
observed that the best aldehyde substrates typically had
a hydrogen bond acceptor at the 2- or 4-position of the
(hetero)aromatic ring.
TheHBPA-catalysed reaction between fluoropyruvate (4)
and an excellent substrate, 4-pyridinecarboxaldehyde (1 f),
was optimised for preparative application. First, it was shown
that conversion into product was not changed significantly
when a smaller excess of aldehyde substrate was used (92%
conversion with both 50 mm and 27.5 mm aldehyde). Second,
it was shown that the conversion remained high with five-fold
less enzyme (89% conversion with 0.02 mol% enzyme),
though was compromised significantly at even lower loading
(40% conversion with 0.005 mol% enzyme). Third, it was
shown that HPBAwas tolerant of up to 20% v/v DMSO as co-
solvent; however, most aldehydes were soluble in the buffer
alone and those aldehydes that were not, typically, only
required addition of 5–10% v/v DMSO.
A wide range of aldehyde substrates was explored to
determine the scope of our synthetic approach. Typically, an
aldehyde 1 (27.5 mm), fluoropyruvate (4) (25 mm) and
0.02 mol% HBPA were dissolved in 25 mm pH 6.0 MES
buffer. After 24 hr, the crude b-fluoro g-hydroxy a-keto acid
products 5 were efficiently decarboxylated by treatment with
H2O2 (resulting in dramatic simplification of the
19F NMR
spectrum, see Supporting Information). Finally, to facilitate
isolation and purification, the crude acid products were
evaporated to dryness before esterification by treatment with
SOCl2 in ethanol. The enantiomeric excesses of the products
were determined by integration of the 282 MHz 19F spectra of
the corresponding (R)- and (S)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoic esters (Supporting Information).[20] Our
results are summarized in Table 1.
Our chemoenzymatic synthesis of a-fluoro b-hydroxy
esters was successful with a wide range of heteraromatic and
aromatic aldehydes (Table 1). The HBPA-catalysed reaction
was generally highly diastereoselective, and, after purifica-
tion, a single diastereomeric product was often observed. In
all cases, the major diastereomeric product was shown to have
> 98% ee. The absolute and relative configuration of 3 f was
determined by X-ray crystallography, and that of 3g deter-
mined by X-ray crystallographic analysis of the corresponding
camphanic ester 7g (Figure 2). The relative configuration of
the other esters 3 was determined by correlation of the
19F NMR spectra (Supporting Information). Specifically, the
3JHF values were diagnostic
[9b] of the relative configuration of
the a-fluoro b-hydroxy esters 3 (syn :  24 Hz; anti :  18 Hz).
Figure 1. Reaction between fluoropyruvate and 4-pyridinecarboxalde-
hyde catalysed by HBPA. A) Overview of the reaction. B) 282 MHz 19F
spectrum of fluoropyruvate in its keto and hydrated forms in 25 mm
pH 6.0 MES buffer. C) Addition of 0.1 mol% HBPA results, after 24 h,
in the appearance of double doublets corresponding to the keto and
hydrated forms of the major (93%) and minor (7%) diastereomers 5 f.
D) Selected examples of accepted aldehyde substrates, together with
percentage conversions.
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These data are consistent with the syn-configured esters
adopting a conformation in which the fluorine and hydroxy
groups adopt a gauche arrangement.[21]
Our synthetic approach yields small, polar molecules that
may have value in drug discovery applications. To understand
this value, we determined the molecular properties of the a-
fluoro b-hydroxy esters 3a–n ; the intermediate carboxylic
acids 6a–n ; and the corresponding 2-fluoro 1,3-diols
8a–n (see Supporting Information for the synthesis of an
exemplar 1,3-diol) (Figure 3). Most of these compounds meet
guidelines that have been established both for high-quality
fragments[22] and building blocks[17] for drug discovery.
In conclusion, we have developed a robust chemoenzy-
matic synthesis of a-fluoro b-hydroxy esters. The scope of the
approach is broad, enabling the conversion of many aromatic
and heteroaromatic aldehydes into chiral products with
> 98% ee and high diastereoselectivity. Crucially, the syn
diasteroselectivity of the process complements the anti
selectivity of a recent organocatalysed synthesis of a-fluoro
thioesters.[12] Moreover, the distinctive products have molec-
ular properties suitable for application as high-quality frag-
ments and building blocks for drug discovery.
Table 1: Chemoenzymatic synthesis of a-fluoro b-hydroxy esters.
Entry Product Yield[a] syn :anti[b] ee[c]
1 71% >98:<2 >98%
2 71% >98:<2 >98%
3[d] 60% >98:<2 >98%
4 51% 93:7 >98%
5 29% 83:17 >98%
6 57% 90:10 >98%
7[d] 76% 94:6 >98%
8[d] 38% 92:8 >98%
9[d] 25% >98:<2 >98%
10 43% 94:6 >98%
11 45% 93:7 >98%
12[d] 70% >98:<2 >98%
13 41% 94:6 >98%
14 57% 93:7 >98%
[a] Yield of purified product. The absolute and relative configuration of
the major diastereoisomer is as drawn. [b] Diastereomeric ratio of
purified products. [c] The enantiomeric excess of the major product was
determined by conversion of the purified product into (R)- and (S)-3,3,3-
trifluoro-2-methoxy-2-phenylpropanic esters. [d] Biotransformations
were performed in solutions of MES buffer with 10% DMSO as a co-
solvent to solubilise aldehydes.
Figure 2. X-ray crystal structures of a-fluoro b-hydroxy acid derivatives.
A) X-ray structure of ester 3 f. B) X-ray crystal structure of 7g. The
thermal ellipsoids are set at 50% probability. Color code: C gray, H
white, red O, yellow F, blue N, brown Br.
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Experimental Section
General procedure: b-fluoropyruvic acid sodium salt (0.50 mmol in
25 mm aq. MES buffer, final conc. 25 mm) followed by aldehyde
(0.55 mmol in 25 mm aq. MES buffer, final conc. 27.5 mm) was added
to HBPA (250 mgmL¢1 enzyme in 25 mm MES buffer, pH 6.0, final
vol. 20 mL), and the reaction mixture was left to stand at RT for 24 h
before the addition of solution of H2O2 (30% aq. solution, 150 mL).
After 30 min of vigorous stirring, the reaction mixture was cooled to
0 8C and Na2S2O5 (solid) was slowly added, before the water was
removed in vacuo to reveal a crude product. SOCl2 (200 mL,
1.03 mmol) was slowly added to a suspension of the crude product
in EtOH (10 mL) at 0 8C and stirred at RT for 4 h before being cooled
to 0 8C and made alkaline with NaHCO3 (sat. aq. sol). The resulting
mixture was extracted with EtOAc (3× 10 mL), the combined organic
layers were washed with H2O (2× 30 mL), dried (MgSO4), filtered
and concentrated in vacuo to reveal a crude product.
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Figure 3. Molecular properties of the a-fluoro b-hydroxy esters
3a–n (circles), the a-fluoro b-hydroxy acids 6a–n (triangles) and the
corresponding 2-fluoro 1,3-diols 8a–n (squares).
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